UT Health San Antonio becomes first civilian center in South Texas to launch FDA-approved radiotherapy treatment for advanced prostate cancer

October 6, 2023

  The University of Texas Health Science Center at San Antonio (UT Health San Antonio) announces the successful launch of Pluvicto, a radiopharmaceutical used to treat patients with advanced metastatic prostate cancer. Approved by the U.S. Food and Drug Administration in March of 2022, Pluvicto is a novel targeted molecular therapy that delivers radiation treatment […]





Mays Cancer Center: Targeting certain molecular interactions could yield new strategies for treating prostate cancer

October 5, 2023

Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio has discovered that altering certain molecular interactions could yield new strategies for treating prostate cancer and related diseases. The study focuses on androgen receptors (AR), which are protein molecules that help direct the development of male sexual characteristics, […]





Barshop Institute team discovers why liver disease is more severe in older people

October 3, 2023

Lower levels of a protective protein lead to liver inflammation, scarring Researchers at The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) have identified a molecular pathway that connects aging to end-stage liver disease. A set of mechanistic processes, observed in mice fed an ethanol diet to mimic […]